Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM)

• Tipo: Outra Publicação em Revista Científica Internacional
• Data: 2011

Autores

Souto, SB (Autor) Outra; Souto, EB (Autor) Outra; Braga, DC (Autor) Outra; Medina, JL (Autor) Outra

Revista

Título: European Journal of Clinical Pharmacology

Vol. 67

Páginas: 653-661

ISSN: 0031-6970

Editora: Springer Nature

Indexação

ISI Web of Knowledge - 20 Citações

Scopus - 23 Citações

Outras Informações

ID Authenticus: P-002-Q45

DOI: 10.1007/s00228-011-1038-z

Abstract (EN): The urgent need to treat type 2 diabetes mellitus (T2DM), which is currently reaching epidemic proportions, has been a major focus of healthcare systems and policy makers worldwide. Pharmacological treatment and lifestyle interventions together with the control of cardiovascular risk factors are the main strategies to prevent or delay the onset of T2DM. The present review discusses the state of the art knowledge of effective therapeutic approaches (metformin, thiazolidinediones, nateglinides, alpha-glucosidase inhibitors, incretin-based and angiotensin-based therapies, weight reducers, statins, fibric acid derivatives), including surgery, and identifies the major lifestyle changes for specific target groups.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 9